Riskpilot← Back to searchSign inGet full accessOVERGADES DYREKLINIK ODENSE ApS
APSActiveCVR 30177339Overgade 43Veterinary activities · NACE 7500Est. 200714 employees
Revenue 2025
DKK 5,9M
+18% vs 2024
EBITDA margin
30.8%
+54% vs 2024
Equity ratio
37.7%
Financial strength
Net profit 2025
DKK 1,1M
+83% vs 2024
| Revenue | DKK 5,9M | +18% |
| EBITDA | DKK 1,8M | +54% |
| Net profit | DKK 1,1M | +83% |
| Total assets | DKK 3,3M | +18% |
| Equity | DKK 1,2M | +69% |
| Employees | 14 | — |
Legal name
OVERGADES DYREKLINIK ODENSE ApS
CVR number
30177339
Legal form
Anpartsselskab
NACE code
7500 · Veterinary activities
Founded
1. januar 2007
Share capital
DKK 125.000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 3 direktører i forening.
Company purpose
Selskabets formål er at drive dyreklinik og hermed beslægtet virksomhed.
Address
Overgade 43
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4.204 | 4.508 | 4.789 | 4.945 | 5.851 |
| Staff expenses | -3.254 | -3.480 | -3.818 | -3.758 | -4.048 |
| EBITDA | 951 | 1.028 | 971 | 1.169 | 1.804 |
| Depreciation & amort. | -312 | -351 | -338 | -306 | -315 |
| EBIT | 638 | 677 | 633 | 863 | 1.488 |
| Net financials | -58 | -94 | -79 | -71 | -57 |
| Profit before tax | 580 | 583 | 553 | 792 | 1.432 |
| Tax | 128 | 128 | 122 | 183 | 316 |
| Net profit | 452 | 454 | 431 | 609 | 1.116 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3.759 | 3.882 | 3.385 | 2.788 | 3.293 |
| Equity | 703 | 707 | 684 | 735 | 1.242 |
| Long-term debt | 679 | 603 | 0 | 0 | 0 |
| Short-term debt | 2.217 | 2.499 | 2.625 | 1.981 | 1.982 |
| Total debt | 2.895 | 3.102 | 2.625 | 1.981 | 1.982 |
EBITDA margin
30.8%
This company
15.8%
Market median
+95% vs market
20212025
Equity ratio
37.7%
This company
38.2%
Market median
+1% vs market
20212025
Return on equity
89.8%
This company
18.4%
Market median
+388% vs market
20212025
Net profit margin
19.1%
This company
8.1%
Market median
+136% vs market
20212025
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
20212025
Debt / equity
1.65×
This company
0.62×
Market median
-166% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
MC Management | Management | 2024 |
TA Management | Management | 2007 |
TS Management | Management | 2024 |
CA Management | Management | 2024 |
| Former (2) | ||
Uv Management | Management | 2007 – 2015 |
PA Management | Management | 2007 – 2007 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2024 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2024 | |
| Company | 20–24.99% | 20–24.99% | 2024 | |
| Company | 10–14.99% | 10–14.99% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ASTONO-MORTENSEN HOLDING ApS
OVERGADES DYREKLINIK ODENSE ApS Board members of OVERGADES DYREKLINIK ODENSE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Cecilie Olesen | Management | 0 companies |
| Tune Aas Mortensen | Management | 0 companies |
| Ulrik von Sehested Schousboe | Management | 0 companies |
| Peter Andreas Stakemann | Management | 0 companies |
| Therese Susiah Holbæk Astono | Management | 0 companies |
| Cecilie Ambo Madsen | Management | 0 companies |